Skip to content

Study on the effect and mechanism of treating anxiety and depression in elderly patients with hypertension

Study on the effect and mechanism of treating anxiety and depression in elderly patients with hypertension

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037299
Enrollment
Unknown
Registered
2020-08-27
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Sponsors

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Patients with essential hypertension who have taken antihypertensive drugs or meet the diagnostic criteria of Hypertension in Chinese Guideline for Prevention and Treatment of Hypertension 2010: under the condition of not using antihypertensive drugs, blood pressure of patients with systolic blood pressure >= 140mmHg and/or diastolic blood pressure >= 90mmHg shall be measured three times on the same day; 2. The questionnaire on the mental health status of patients was conducted by professional psychological consultants, including GAD7 anxiety Screening Scale and Hamilton anxiety Scale (HAMA), GAD7>= 5 and = 7 and = 7 and <= 24 points. 3. Conform to the syndrome differentiation standard of Yin deficiency and Yang hyperactivity in TCM; 4. Age in 60~90 years old, gender is not limited; 5. Stop taking other similar Traditional Chinese medicines and proprietary Chinese medicines during clinical observation; 6. Cooperate with the questionnaire and the investigator, informed consent.

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction, unstable angina pectoris; 2. Patients with other cardiac diseases or severe cardiac insufficiency (NYHA cardiac function grade > level III); 3. Patients with poor control after standardized treatment of hypertension (blood pressure > 170/105mmhg); 4. severe arrhythmia, continuous rapid atrial fibrillation (calm state average ventricular rate > 100 times/min), atrial flutter (calm state average ventricular rate > 100 times/min), frequent ventricular premature beats (24 hours of premature ventricular beats > 7200 times) or ventricular tachycardia; 5. patients with severe primary diseases such as brain, liver, kidney and hematopoietic system; 6. Diabetic patients with unstable blood glucose control and diabetic ketoacidosis; 7. Patients with severe mental illness, such as hallucinations, delusions, panic attacks and suicidal behavior; 8. Women who are pregnant or breast-feeding, and men and women of childbearing age who have recently had family planning; 9. Patients with allergic constitution who are allergic to the tested drugs.

Design outcomes

Primary

MeasureTime frame
Score on the GAD7 Anxiety screening scale;Hamilton Anxiety Scale (HAMA) score;Hamilton Depression Scale (HAMD) score;gallbladder contraction;Corticotropin;

Secondary

MeasureTime frame
blood pressure;Blood pressure variability;Integral of TCM syndrome curative effect;Sleep Status Self-rating scale;Plasma serotonin;glutamate;

Countries

China

Contacts

Public ContactTao Liyu

Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine?

taoliyu37@163.com+86 13524993507

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026